Federal grants to Janusq LLC
Janusq LLC in Rocky River, Ohio received $1.6 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Aging Research, with $836,248. In fiscal 2025 it was awarded $1.1 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$1.6 million
- Awards4
- Awarded in FY 2025$1.1 million
- Largest award$576,664
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $240,938 |
| FY 2022 | 1 | $259,584 |
| FY 2023 | 0 | $0 |
| FY 2024 | 0 | $0 |
| FY 2025 | 2 | $1.1 million |
Programs that fund Janusq LLC
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 2 | $836,248 |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 2 | $731,439 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $1.6 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Pharmacokinetics and in vivo efficacy of DA1 macrocyclic peptides in a murine model of alzheimer's disease - project summary/abstract janusq, LLC is a startup biotech company, spun out of case western reserve university, that is developing a peptide-based therapy for treatment of mitochondrial dysfu | Aging Research | September 19, 2025 | $576,664 |
| In vivo efficacy and in vitro toxicity assessment of peptide-based therapy HV-3 for the treatment of huntington's disease - project summary/abstract janusq, LLC—a startup biotech company spun out of case western reserve university—is developing a peptide-based therapy for the treatment of mitochondr | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 12, 2025 | $490,501 |
| Pharmacokinetic and pharmacodynamic assessment of peptide-based therapy DA1 for the treatment of alzheimer's disease - project summary/abstract janusq, LLC is a startup biotech company, spun out of case western reserve university, and developing a peptide-based therapy for treatment of mitochondrial | Aging Research | September 16, 2022 | $259,584 |
| Pharmacokinetic assessment of peptide-based therapy HV-3 for the treatment of huntington's disease - project summary/abstract janusq, LLC is a startup biotech company, spun out of case western reserve university, and developing a peptide-based therapy for the treatment of mitochondrial dysfunction i | Extramural Research Programs in the Neurosciences and Neurological Disorders | December 15, 2020 | $240,938 |
Questions people ask
How much federal grant money does Janusq LLC get?
$1.6 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Janusq LLC the most?
The Department of Health and Human Services, with $1.6 million in 4 awards.
What is Janusq LLC's largest federal grant?
$576,664 under Aging Research, with its first action in the period on September 19, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Janusq LLC?
Its largest are Aging Research and Extramural Research Programs in the Neurosciences and Neurological Disorders.
Other grant recipients in Rocky River
Largest federal grant recipients in Ohio · Federal grants in Ohio